Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr:41:106-12.
doi: 10.1016/j.canep.2016.01.010. Epub 2016 Feb 18.

Use of claims data to estimate annual cervical cancer screening percentages in Portland metropolitan area, Oregon

Nasreen Abdullah  1 , Robert S Laing  2 , Susan Hariri  3 , Collette M Young  2 , Sean Schafer  2
Affiliations

Use of claims data to estimate annual cervical cancer screening percentages in Portland metropolitan area, Oregon

Nasreen Abdullah et al. Cancer Epidemiol. 2016 Apr.

Abstract

Background: Human papillomavirus (HPV) vaccine should reduce cervical dysplasia before cervical cancer. However, dysplasia diagnosis is screening-dependent. Accurate screening estimates are needed.

Purpose: To estimate the percentage of women in a geographic population that has had cervical cancer screening.

Methods: We analyzed claims data for (Papanicolau) Pap tests from 2008-2012 to estimate the percentage of insured women aged 18-39 years screened. We estimated screening in uninsured women by dividing the percentage of insured Behavioral Risk Factor Surveillance Survey respondents reporting previous-year testing by the percentage of uninsured respondents reporting previous-year testing, and multiplying this ratio by claims-based estimates of insured women with previous-year screening. We calculated a simple weighted average of the two estimates to estimate overall screening percentage. We estimated credible intervals using Monte-Carlo simulations.

Results: During 2008-2012, an annual average of 29.6% of women aged 18-39 years were screened. Screening increased from 2008 to 2009 in all age groups. During 2009-2012, the screening percentages decreased for all groups, but declined most in women aged 18-20 years, from 21.5% to 5.4%. Within age groups, compared to 2009, credible intervals did not overlap during 2011 (except age group 21-29 years) and 2012, and credible intervals in the 18-20 year group did not overlap with older groups in any year.

Conclusions: This introduces a novel method to estimate population-level cervical cancer screening. Overall, percentage of women screened in Portland, Oregon fell following changes in screening recommendations released in 2009 and later modified in 2012.

Keywords: Cervical cancer screening; Cervical dysplasia; Cervical intraepithelial neoplasia (CIN); HPV vaccines; Human papillomavirus (HPV).

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

All authors declare no conflicts of interest, financial or otherwise.

Figures

Fig. 1.
Fig. 1.
Estimating annual Pap screening percentage by insurance status.
Fig. 2.
Fig. 2.
Percentage of women who reported cervical cancer screening in the past 12 months by age group, Oregon 2008–2012.
See this image and copyright information in PMC

References

    1. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al., Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia, Vaccine 26 (August (19) Suppl. (10)) (2008) K1–K16. - PubMed
    1. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al., American Cancer Society guideline for the early detection of cervical neoplasia and cancer, CA: Cancer J. Clin 52 (November–December (6)) (2002) 342–362. - PubMed
    1. Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, et al., The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions, Cancer Causes Control: CCC 23 (February (2)) (2012) 281–288. - PubMed
    1. Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, et al., A population-based evaluation of cervical screening in the United States: 2008–2011. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 23 May (5) (2014) 765–773. - PMC - PubMed
    1. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R, Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys, J. Natl. Cancer Inst 93 (22) November (21) (2001) 1704–1713. - PubMed

Publication types

Substances